Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicenter study of antidepressant drug overdoses

PharmacoEconomics

Volumn 11, Issue 1, 1997, Pages 48-55

  Revicki, Dennis A ^a   Palmer, Cynthia S ^a   Phillips, Scott D ^b   Reblando, Joseph A ^a   Heiligenstein, John H ^c   Brent, Jeffrey ^b   Kulig, Kenneth ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG OVERDOSE; FEMALE; HEALTH CARE COST; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031015092     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199711010-00006     Document Type: Article

References (22)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-months prevalence of DSM-III-R psychiatric disorders in the United States: results form the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19
2. Greenberg PE, Stiglin LE, Finkelslein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405-18
3. Guze SB, Robins E. Suicide among primary affective disorders. Br J Psychiatry 1970; 117: 437-8
4. Brent DA, Kupfer DJ, Bromet EJ, et al. The assessment and treatment for patients at risk for suicide. In: Frances AJ, Hale RE, editors. Review of psychiatry VII. Washington, DC: American Psychiatric Press, 1988: 353-86
5. Bulik CM, Carpenter LL, Kupfer DJ, et al. Features associated with suicide attempts in recurrent major depression. J Affect Disord 1990; 18: 29-37
6. Kapour S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992; 268: 3441-5
7. Frommer DA, Kulig KW, Marx JA, et al. Tricyclic antidepressant overdose: a review. JAMA 1987; 257 (4): 521-6
8. Litovitz TL, Holm KC, Clancy C, et al. 1992 Annual Report of the American Association of Poison Control Centers Toxic Exposures Surveillance System. Am J Emerg Med 1993; 11 (5): 494-555
9. Cassidy S, Henry J. Fatal toxicily of antidepressant drugs in overdose. BMJ 1987; 295: 1021-4
10. Farmer RD, Pinder RM. Why do fatal overdose rates vary between antidepressants? Acta Psychiatr Scand 1989; 354 Suppl.: 25-35
11. Linakis JG, Frederick KA. Poisoning deaths not reported to the regional poison control center. Ann Emerg Med 1993; 22: 1822-8
12. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995; 310: 215-8
13. Isacsson G, Holmgren P, Wasserman D, et al. Use of antidepressants among people committing suicide in Sweden. BMJ 1994; 308: 506-9
14. Roy TM, Ossorio MA, Cipolla LM, et al. Pulmonary complications after tricyclic antidepressant overdose. Chest 1989; 96: 852-6
15. Borys DJ, Setzer SC, Ling LJ, et al. Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med 1992; 10: 115-20
16. McCombs JS, Nichol MB, Stimmel GL, et al. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry 1990; 51: 60-9
17. Phillips S, Brent J, Kulig K, et al. Fluoxetine versus tricyclic antidepressants. A prospective multicenter study of antidepressant drug overdoses: the clinical perspective [abstract]. Vet Human Toxicol 1994; 36: 378
18. U.S. Department of Health and Human Services. Health Care Financing Administration. Health care financing review: Medicare and Medicaid statistical supplement. Baltimore: Office of Research and Demonstrations, 1995
19. Conover WJ. Practical nonparametric statistics. 2nd ed. New York: John Wiley & Sons, 1980
20. Mondragon D. Hospital costs of societal violence. Arizona 1989. Med Care 1992; 30: 453-60
21. Washington State Department of Health. An assessment of suicide in Washington State. Olympia, WA: Washington State Injury Prevention Program. Washington State Department of Health, Jun 1994: 1-15
22. Palmer CS, Revicki DA, Halpern MT, et al. The cost of suicide and suicide attempts in the United States. Clin Neuropharmacol 1995; 18 Suppl. 3: 525-33